G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,332,084 | -13.3% | 2,543,006 | -6.6% | 0.00% | 0.0% |
| Q1 2023 | $7,300,057 | +47753.5% | 2,723,902 | -3.0% | 0.00% | -60.0% |
| Q4 2022 | $15,255 | -100.0% | 2,809,444 | -4.3% | 0.01% | -63.0% |
| Q3 2022 | $36,662,000 | +221.5% | 2,935,332 | +27.2% | 0.03% | +237.5% |
| Q2 2022 | $11,404,000 | -35.1% | 2,308,555 | -0.1% | 0.01% | -20.0% |
| Q1 2022 | $17,565,000 | -24.1% | 2,311,138 | +1.9% | 0.01% | -23.1% |
| Q4 2021 | $23,157,000 | -0.7% | 2,268,074 | +30.5% | 0.01% | -7.1% |
| Q3 2021 | $23,327,000 | +16.2% | 1,738,211 | +90.0% | 0.01% | +7.7% |
| Q2 2021 | $20,072,000 | – | 914,838 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |